Journal article
FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss
Cell metabolism, Vol.20(4), pp.670-677
10/07/2014
DOI: 10.1016/j.cmet.2014.07.012
PMCID: PMC4192037
PMID: 25130400
Abstract
The mechanism by which pharmacologic administration of the hormone FGF21 increases energy expenditure to cause weight loss in obese animals is unknown. Here we report that FGF21 acts centrally to exert its effects on energy expenditure and body weight in obese mice. Using tissue-specific knockout mice, we show that βKlotho, the obligate coreceptor for FGF21, is required in the nervous system for these effects. FGF21 stimulates sympathetic nerve activity to brown adipose tissue through a mechanism that depends on the neuropeptide corticotropin-releasing factor. Our findings provide an unexpected mechanistic explanation for the strong pharmacologic effects of FGF21 on energy expenditure and weight loss in obese animals.
Details
- Title: Subtitle
- FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss
- Creators
- Bryn M Owen - Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USAXunshan Ding - Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USADonald A Morgan - Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USAKatie Colbert Coate - Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USAAngie L Bookout - Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USAKamal Rahmouni - Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USASteven A Kliewer - Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: steven.kliewer@utsouthwestern.eduDavid J Mangelsdorf - Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: davo.mango@utsouthwestern.edu
- Resource Type
- Journal article
- Publication Details
- Cell metabolism, Vol.20(4), pp.670-677
- Publisher
- United States
- DOI
- 10.1016/j.cmet.2014.07.012
- PMID
- 25130400
- PMCID
- PMC4192037
- ISSN
- 1550-4131
- eISSN
- 1932-7420
- Grant note
- R01DK067158 / NIDDK NIH HHS R01 DK067158 / NIDDK NIH HHS HL084207 / NHLBI NIH HHS Howard Hughes Medical Institute GM007062 / NIGMS NIH HHS 1F32DK098908 / NIDDK NIH HHS P01 HL084207 / NHLBI NIH HHS T32 GM007062 / NIGMS NIH HHS F32 DK098908 / NIDDK NIH HHS
- Language
- English
- Date published
- 10/07/2014
- Academic Unit
- Iowa Neuroscience Institute; Neuroscience and Pharmacology; Internal Medicine
- Record Identifier
- 9984040264902771
Metrics
9 Record Views